Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)
Clinical trial NCT02096042 · TERMINATED
Trial details
- NCT number
- NCT02096042
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.